Delivery Order SPE2DB20D1100-SPE2DB25FA7Q9

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,364.69, is for the delivery of DEXMETHYLPHENIDATE ER 20 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,016.10 and is a delivery order contract with a firm fixed price pricing type. The contract is to provide DEXMETHYLPHENIDATE ER 15 MG CP 100S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of February 13, 2025. This award...
This federal contract award is for the delivery of DEXMETHYLPHENIDATE ER 15 MG CP 100S, a generic prescription pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,048.31 and has an ultimate completion date of February 21, 2025. This contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S. The fixed-price delivery order, valued at $1,063.28, has a period of performance through February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,097.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 10 MG CP 100S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a period of performance through February 5, 2025. This contract award is not associated with a set-aside designation....
This is a federal contract award valued at $5,164.09 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and covers the delivery of DEXMETHYLPHENIDATE ER 15 MG CP 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. This award is part of a larger...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4565089812 units of DEXMETHYLPHENIDATE ER 15 MG CP. The firm-fixed-price delivery order, valued at $3,045.64, has a completion date of July 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the award is associated with a larger Indefinite...
This federal contract award, valued at $2,307.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product, with a completion date of February 12, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside program, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,825.48, is for the delivery of DEXMETHYLPHENIDATE ER 15 MG CP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024 and is structured as a Firm Fixed Price delivery order. This award is not associated with a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,103.69, is for the delivery of 4,563,152,813 units of DEXMETHYLPHENIDATE ER 15 MG CP. The contract has an ultimate completion date of December 21, 2023 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA7Q9
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the procurement of DEXMETHYLPHENIDATE ER 15 MG CP 100S, a pharmaceutical product. The $1,456.48 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/28/25, 10:55 AM